Park Medi World IPO GMP, Date, Price Band & Review

The size of the Park Medi World IPO is ₹920 crores, consisting of a fresh issue of 4.75 crore shares worth ₹770 crores and an offer-for-sale (OFS) of 0.93 crore shares totaling ₹150 crores. It is a book-built IPO, with a price band at ₹154-₹162 per share. The issue will open on 10 December 2025 and will close the same day with the allotment date of 15 December 2025. Listing will be on 17 December 2025 on BSE and NSE.

Company Background

Park Medi World Limited is a privately owned chain of hospitals established in 2011, based largely in North Eastern India, headquartered in New Delhi. It operates 13 multi-specialty hospitals under the 'Park' brand in Haryana, New Delhi, Punjab and Rajasthan with an aggregate capacity of 3,000 beds as of September 2024. All facilities are NABH-accredited and 7 are also approved by NABL, aimed at providing high-quality, affordable health care.

Operations and Product Range

Facility and Production

Park Medi World has received NABH accreditation for all 13 proprietary hospitals with 805 ICU beds, 63 OTs, an oxygen generation plant across locations and two exclusive cancer units. It provides more than 30 super-specialities, including neurology, oncology, urology, gastroenterology, orthopaedics and critical care. As of September 2024, it has a staff of 891 doctors, including senior consultants, 1,912 nurses, 671 allied health professionals and employs 1,761 ancillary staff. ​

Brands and Market Presence

The ‘Park’ brand markets itself as the biggest private hospital chain in Haryana with a cluster-based approach to bring efficiency and accessibility to Tier II/III cities. Features treatments that span a wide spectrum of patients located in North India, with a special emphasis on internal medicine, general surgery and oncology. The model is scalable with targeted growth and acquisitions.

Park Medi World IPO Revenue Channels

The majority of income is generated from hospital operations, including super-speciality services, inpatient/outpatient treatment and diagnostics. The total revenue for the fiscal FY2024 was ₹1,263.08 crore and PAT was ₹152.01 crore; Q2 and H1 FY2025 (Sep 2024) earned it an income of ₹707.45 crore and a PAT of ₹112.89 crore, along with a borrowings figure that stubbornly stayed at just under ₹648.96 crore. Expansion has been fuelled by increasing occupancy, service mix and regional leadership.

Management and Shareholding

Promoters and Shareholding

The promoters of Park Medi World IPO are Dr. Ajit Gupta and Dr. Ankit Gupta, both doctors with sufficient experience in the healthcare industry who built and scaled the chain. The pre-issue shareholding is 38.44 crore shares, on which the OFS enables the promoters to cut part of their holding, while the fresh issue brings more such funds, retaining promoter control post-IPO.

Board Members

The Park Medi World IPO board is headed by promoters Dr. Ajit Gupta (Chairman and MD) and Dr. Ankit Gupta, along with independent directors and clinicians, ensuring that clinical and operational governance measures are in place.